CA1224144A - Sang entier synthetique et procede de preparation - Google Patents
Sang entier synthetique et procede de preparationInfo
- Publication number
- CA1224144A CA1224144A CA000502710A CA502710A CA1224144A CA 1224144 A CA1224144 A CA 1224144A CA 000502710 A CA000502710 A CA 000502710A CA 502710 A CA502710 A CA 502710A CA 1224144 A CA1224144 A CA 1224144A
- Authority
- CA
- Canada
- Prior art keywords
- phase
- coacervate
- whole blood
- blood
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000502710A CA1224144A (fr) | 1981-12-31 | 1986-02-25 | Sang entier synthetique et procede de preparation |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33606181A | 1981-12-31 | 1981-12-31 | |
| US336,061 | 1981-12-31 | ||
| US37239382A | 1982-04-27 | 1982-04-27 | |
| US372,393 | 1982-04-27 | ||
| CA000403488A CA1206096A (fr) | 1981-12-31 | 1982-05-21 | Sang entier synthetique et methode de production |
| CA000502710A CA1224144A (fr) | 1981-12-31 | 1986-02-25 | Sang entier synthetique et procede de preparation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000403488A Division CA1206096A (fr) | 1981-12-31 | 1982-05-21 | Sang entier synthetique et methode de production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1224144A true CA1224144A (fr) | 1987-07-14 |
Family
ID=26990018
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000403488A Expired CA1206096A (fr) | 1981-12-31 | 1982-05-21 | Sang entier synthetique et methode de production |
| CA000502710A Expired CA1224144A (fr) | 1981-12-31 | 1986-02-25 | Sang entier synthetique et procede de preparation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000403488A Expired CA1206096A (fr) | 1981-12-31 | 1982-05-21 | Sang entier synthetique et methode de production |
Country Status (3)
| Country | Link |
|---|---|
| CA (2) | CA1206096A (fr) |
| DE (1) | DE83469T1 (fr) |
| IL (1) | IL65867A0 (fr) |
-
1982
- 1982-05-21 CA CA000403488A patent/CA1206096A/fr not_active Expired
- 1982-05-21 DE DE1982302620 patent/DE83469T1/de active Pending
- 1982-05-24 IL IL65867A patent/IL65867A0/xx unknown
-
1986
- 1986-02-25 CA CA000502710A patent/CA1224144A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IL65867A0 (en) | 1984-05-31 |
| CA1206096A (fr) | 1986-06-17 |
| DE83469T1 (de) | 1983-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shannon et al. | Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study | |
| US4963526A (en) | Oral insulin and a method of making the same | |
| Horber et al. | Plasma reciprocal pool specific activity predicts that of intracellular free leucine for protein synthesis | |
| Brodie et al. | The fate of procaine in man following its intravenous administration and methods for the estimation of procaine and diethylaminoethanol | |
| Ellul-Micallef et al. | Effect of intravenous prednisolone in asthmatics with diminished adrenergic responsiveness | |
| US4343797A (en) | Synthetic whole blood and a method of making the same | |
| US4849405A (en) | Oral insulin and a method of making the same | |
| Corrigan Jr et al. | Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency | |
| US4439424A (en) | Synthetic whole blood | |
| Cohn | Chemical, physiological, and immunological properties and clinical uses of blood derivatives | |
| Elliott | A therapeutic trial of fatty acid supplementation in cystic fibrosis | |
| CA2122480A1 (fr) | Vesicules de membranes plaquettaires reconstituees | |
| KR20030053507A (ko) | 동적-팽창 작용을 하는 폐계면활성제 조성물 | |
| Hoffer et al. | Effects of meal consumption on whole body leucine and alanine kinetics in young adult men | |
| US4558032A (en) | Synthetic whole blood substitute and a method of making the same | |
| WO1983002228A1 (fr) | Sang entier synthetique et son procede de production | |
| EP0124527B1 (fr) | Sang entier synthetique a base de gelatine et son procede de fabrication | |
| Albertine et al. | In vivo labeling of neutrophils using a fluorescent cell linker | |
| Pearce et al. | HBOC-201 (hemoglobin glutamer-250)(bovine), hemopure®): clinical studies | |
| CA1224144A (fr) | Sang entier synthetique et procede de preparation | |
| US4874742A (en) | Synthetic whole blood and a process for preparing the same | |
| Burman et al. | Acute anaphylaxis, pulmonary oedema, and intravascular haemolysis due to cryoprecipitate. | |
| CN100386078C (zh) | 尼莫地平乳注射液及制备方法 | |
| AU583272B2 (en) | Coacervate system synthetic whole blood substitute | |
| Tong et al. | Pulmonary function studies in Plasmodium falciparum malaria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |